BMP Sunstone, a specialty pharmaceutical company, has announced that its wholly-owned subsidiary, Sunstone Pharmaceutical, has signed an agreement to acquire 'Runchang capsule', a liquid-filled hard capsule used to treat constipation.
Subscribe to our email newsletter
Sunstone will also receive the entire liquid-filled (LFHC) filling and sealing production line, as well as related LFHC technology from Darentang Pharmaceutical, which is a subsidiary of Tianjin Zhongxin Pharmaceutical Group.
Upon completion of the transaction, BMP Sunstone will become the only current manufacturer of LFHC capsules in China. The company plans to start promoting the Runchang capsule in the Chinese market in late 2009.
David Gao, CEO of BMP Sunstone, said: “Besides acquiring an approved product, the acquisition will afford us the sole proprietary ownership of LFHC technology in China. We plan to further utilize the targeted-release technology to our existing products to enhance our competitive position and, ultimately, our market share.
“We intend to fully leverage our existing channels and sales platform to capitalize on the market demand for constipation products, especially within the areas of women’s and children’s health.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.